Latest Breaking News On - Dror ben asher - Page 1 : vimarsana.com

RedHill Biopharma : Announces First Patient Enrolled in U.S. Government- Supported COVID-19 Study - Form 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K .

RedHill Biopharma : and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebola - Form 6-K -December 20, 2023 at 08:58 am EST

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K .

RedHill Biopharma : NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS - Form 6-K -October 16, 2023 at 04:09 pm EDT

NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS To be held on November 16, 2023 The Extraordinary General.

Form F-3 RedHill Biopharma Ltd.

RedHill Biopharma : NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS - Form 6-K -October 10, 2023 at 09:11 am EDT

NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS To be held on November 16, 2023 The Extraordinary General.

RedHill Biopharma Provides H1/23 Financial Results and Operational Highlights

RHB-107 included in the U.S. Department of Defense-supported ACESO PROTECT multinational platform trial for early COVID-19 outpatient treatment; The.

RedHill Announces Additional U.S. Government Funding for Opaganib Nuclear Countermeasure Development

TEL AVIV - RedHill Biopharma Ltd. , a specialty biopharmaceutical company, today announced that opaganib[1] has been awarded a further $1.7 million in U.S. Government funding, via a Small Business.

RedHill Announces Additional U.S. Government Funding for Opaganib Nuclear Countermeasure Development

Opaganib awarded a further $1.7 million in U.S. Government funding for development as a medical countermeasure for gastrointestinal acute radiation syndrome.

RedHill Biopharma's stock soars 10% after company gets U.S. funding to develop treatment for radiation sickness

RedHill Biopharma Ltd.’s stock soared 10% premarket after the company said it has received a further $1.7 million in U.S. government funding for its partner,.

RedHill Biopharma (RDHL) Announces Additional U.S. Government Funding for Opaganib Nuclear Countermeasure Development